Outcomes in COVID-19 iota-carrageenan studies
0
0.5
1
1.5+
All studies 80% 1
394
Improvement, Studies, Patients Relative Risk Cases 80% 1
394
RCTs 80% 1
394
Prophylaxis 80% 1
394
Iota-carrageenan for COVID-19 c19 early.org/g Mar 2023Favors iota-carrageenan Favors control
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Figueroa (DB RCT) 80%
0.20 [0.05-0.78]
symp. case
2/196
10/198
Improvement, RR [CI] Treatment Control Tau2 = 0.00, I2 = 0.0%, p = 0.035
Prophylaxis 80%
0.20 [0.05-0.78]
2/196
10/198
80% improvement All studies 80%
0.20 [0.04-0.89]
2/196
10/198
80% improvement 1 iota-carrageenan COVID-19 study c19 early.org/g Mar 2023Tau2 = 0.00, I2 = 0.0%, p = 0.035
Effect extraction pre-specified (most serious outcome) Favors iota-carrageenan
Favors control
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Figueroa (DB RCT) 80%
0.20 [0.05-0.78]
symp. case
2/196
10/198
Improvement, RR [CI] Treatment Control Tau2 = 0.00, I2 = 0.0%, p = 0.035
Prophylaxis 80%
0.20 [0.05-0.78]
2/196
10/198
80% improvement All studies 80%
0.20 [0.04-0.89]
2/196
10/198
80% improvement 1 iota-carrageenan COVID-19 case result c19 early.org/g Mar 2023Tau2 = 0.00, I2 = 0.0%, p = 0.035
Favors iota-carrageenan
Favors control
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Figueroa (DB RCT) 80%
0.20 [0.05-0.78]
symp. case
2/196
10/198
Improvement, RR [CI] Treatment Control Tau2 = 0.00, I2 = 0.0%, p = 0.035
Prophylaxis 80%
0.20 [0.05-0.78]
2/196
10/198
80% improvement All studies 80%
0.20 [0.04-0.89]
2/196
10/198
80% improvement 1 iota-carrageenan COVID-19 Randomized Controlled Trials c19 early.org/g Mar 2023Tau2 = 0.00, I2 = 0.0%, p = 0.035
Effect extraction pre-specified (most serious outcome) Favors iota-carrageenan
Favors control
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Figueroa (DB RCT) 80%
0.20 [0.05-0.78]
symp. case
2/196
10/198
Improvement, RR [CI] Treatment Control Tau2 = 0.00, I2 = 0.0%, p = 0.035
Prophylaxis 80%
0.20 [0.05-0.78]
2/196
10/198
80% improvement All studies 80%
0.20 [0.04-0.89]
2/196
10/198
80% improvement 1 iota-carrageenan COVID-19 peer reviewed studies c19 early.org/g Mar 2023Tau2 = 0.00, I2 = 0.0%, p = 0.035
Effect extraction pre-specified (most serious outcome) Favors iota-carrageenan
Favors control
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Figueroa (DB RCT) 80%
0.20 [0.05-0.78]
symp. case
2/196
10/198
Improvement, RR [CI] Treatment Control Iota-carrageenan COVID-19 outcomes c19 early.org/g Mar 2023Favors iota-carrageenan
Favors control
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.
Submit
